Retinal Microangiopathy in Patients after Covid-19 Disease

Retinal Microangiopathy in Patients after Covid-19 Disease - ReMiCov

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022874

Enrollment

Registered

2020-08-20

Start date

2020-07-13

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1

Interventions

Group 1: patients post intensive-care treated Covid-19 Group 2: patients post non-intensive-care treated Covid-19 Group 3: healthy controls

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients post Covid-19 disease, healthy controls (Covid-19 negative), Minimum Age of 18 years, both gender

Exclusion criteria

Exclusion criteria: known disease of retinal vasculature, like edema, vasculitis, glaucoma, other degenerative retinal disease

Design outcomes

Secondary

Measure	Time frame
size of avascular foveal Zone in mm², density of microvasculature, thickness of retinal layers. These data can be assessed from OCTA images.	—

Primary

Measure	Time frame
density of cappillary vasculature within macula, measured in mm². Examinations are performed once post Covid-19 disease. Non-invasiv, non-damaging OCTA is used to examine retinal vasculature. This examination will take 15 minutes. On top, a general ophthalmological examination will be performed.	—

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026